Zohreh Kousha Shoar
Pediatric Endocrinology · Santa Barbara, CANPI 1275855728
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 14.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,055, 3.8 times the $280 reported in 2019.
Across 71 payments — averaging $44.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$472
- Medtronic$327
- Sanofi-aventis U.S. LLC$315
- Tolmar, Inc.$302
- Sequel Med Tech, LLC$194
- Dexcom, Inc.$171
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,172100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 10 | $472 |
| Medtronic(2 entities) | 7 | $327 |
| Sanofi-aventis U.S. LLC | 4 | $315 |
| Tolmar, Inc. | 6 | $302 |
| Sequel Med Tech, LLC | 3 | $194 |
| Dexcom, Inc. | 3 | $171 |
| Kyowa Kirin, Inc. | 2 | $169 |
| Pfizer | 3 | $150 |
| Ascendis Pharma Endocrinology Inc | 7 | $144 |
| Rhythm Pharmaceuticals, Inc. | 2 | $134 |
| Sanofi | 1 | $132 |
| AstraZeneca | 2 | $98 |
| Sobi, Inc | 1 | $92 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| AbbVie | 3 | $62 |
| UCB, Inc. | 3 | $61 |
| Companion Medical, Inc. | 2 | $60 |
| Insulet Corporation | 2 | $56 |
| Soleno Therapeutics, Inc. | 1 | $37 |
| Genentech USA, Inc. | 1 | $31 |
| Jazz Pharmaceuticals Inc. | 1 | $30 |
| Mirum Pharmaceuticals, Inc. | 1 | $22 |
| Novo Nordisk | 1 | $20 |
| Abbott | 1 | $15 |
| BETA Bionics, Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$226
- MINIMED 780G$178
- FENSOLVI$173
- TWIIST$172
- CRYSVITA$146
- DEXCOM G7 GSS (161)$135
- DUPIXENT$132
- Imcivree$115
- EUCRISA$110
- TZIELD$107
How this compares
$3,172 in reported general payments places this provider in the 70th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Santa Barbara
- Jordan PinskerSanta Barbara$83K
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
- Lynda PolgreenOrange$167K
- Kevin KaisermanWest Covina$150K
- Amrit BhangooLong Beach$140K
- Mitchell GeffnerLos Angeles$129K
- Stephen GitelmanSan Francisco$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.